Dave Cervi

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis

Yuval Shaked, Francesco Bertolini, Shan Man et al. · Cancer Cell · 2005 · 328 citations

Life Sciences, Genetics, Molecular Genetics +13

Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity

Yuval Shaked, Urban Emmenegger, Shan Man et al. · Blood · 2005 · 256 citations · Full text

Medicine, Oncology, Pharmacology +14

The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells

Yuval Shaked, Dave Cervi, Manuela G. Neuman et al. · Blood · 2005 · 37 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.

Christina R. Lee, Dave Cervi, Amandine Truong et al. · PubMed · 2003 · 27 citations

Medicine, Genetics, Oncology +17

Targeting Cyclooxygenase-2 Reduces Overt Toxicity toward Low-Dose Vinblastine and Extends Survival of Juvenile Mice with Friend Disease

Dave Cervi, Giannoula Klement, Diana Stempak et al. · Clinical Cancer Research · 2005 · 13 citations

Medicine, Oncology, Pharmacology +13